0.05Open0.05Pre Close0 Volume1 Open Interest7.50Strike Price0.00Turnover2197.58%IV1108.00%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1731Delta0.2771Gamma12.50Leverage Ratio-0.0479Theta0.0000Rho2.16Eff Leverage0.0001Vega
Equillium Stock Discussion
is this stock still even alive
$Equillium (EQ.US)$
Equillium Inc. (Nasdaq: EQ), a clinical-stage biotechnology company, recently announced promising topline results from its Phase 2 proof-of-concept (PoC) study of EQ101 in adult patients suffering from moderate, severe, or very-severe alopecia areata (AA). This autoimmune condition, driven by an immune cell attack on hair follicles, leads...
No comment yet